
About Cryoviva Biotech Private Limited
Data last updated:
Cryoviva Biotech Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Rj Corp Limited. It operates in the ivf and maternity care centers segment of the healthcare sector. It was incorporated on 20 June 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85195DL2005PTC137768. Its GSTIN is 06AACCC6069Q1Z4 (Haryana).
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹20 Cr. It was formerly known as Cryobanks International India Private Limited. It is led by directors including Satya Vir Singh and Satyanarayan Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 2/7 Okhla Indl Area Ph – I, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹95.95 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹13.74 Cr (net margin 14.3%) and EBITDA of ₹32.47 Cr (EBITDA margin 33.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 12% over five years.
The company has about 182 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹69 Cr on record. Court records list 83 cases involving the company, including 78 filed by the company and 5 filed against it; 56 cases are pending. The company has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹19.99 Cr; the latest was in February 2021. Its 5 peer companies in the Healthcare industry (IVF and Maternity), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 2 larger and 3 smaller; the largest is Star Fertility Private Limited with revenue of ₹134.74 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cryoviva.in.
Company details
Contact details
Cryoviva Biotech Private Limited's registered office is in New Delhi, Delhi. Its website is cryoviva.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressF – 2/7 Okhla Indl Area Ph – I, New Delhi, Delhi, India – 110020
- IndustryHealthcare, IVF & Maternity Care Centers
To see the full contact details of Cryoviva Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Cryoviva Biotech are hospital and medical care and professional, scientific and technical. In detail, this covers other hospital and medical care activities and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Cryoviva Biotech Private Limited, buy the company report.
Financials of Cryoviva Biotech Private Limited
FY 2025 filings availableCryoviva Biotech Private Limited reported revenue of ₹95.95 Cr (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32.47 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.74 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 33.8% | ||||
| Net Profit Margin | 14.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cryoviva Biotech Private Limited, buy the company report.
Board of directors and KMP of Cryoviva Biotech Private Limited
Cryoviva Biotech Private Limited currently reports 4 directors and 2 key managerial personnel. 12 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satya Vir Singh Also directs: Lineage Healthcare Limited, Parkview City Limited | Director | 14 Jun 2022 | 4 Years 4 Months | Current |
| Vivek Kumar Singh Also directs: Vaib Consultancy Services LLP, Homeshree Housing Finance Limited, Ayadvasu Consulting Private Limited and 1 more | Company Secretary | 14 Nov 2019 | 6 Years 11 Months | Current |
| Satyanarayan Sharma Also directs: CV Biotech Private Limited, Accor Realcon Private Limited, Capital Infracon Private Limited and 3 more | Director | 31 May 2021 | 5 Years 5 Months | Current |
| Rajesh Chopra Also directs: Lineage Healthcare Limited | Director | 14 Jun 2022 | 4 Years 4 Months | Current |
| Raj Pal Gandhi Also directs: Devyani International Limited, Varun Beverages Limited, Kiva Spirits and Company Limited and 5 more | Director | 24 Aug 2011 | 15 Years 2 Months | Current |
| Ashish Arora Also directs: Svasthyam Healthcare Private Limited | Cfo | 28 Nov 2024 | 1 Years 11 Months | Current |
Peer comparison
Cryoviva Biotech Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (IVF and Maternity), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Star Fertility Private Limited | ₹134.74 Cr (FY 2025) | -1.0% | Secunderabad, Telangana, India | |||
| Arc International Fertility and Research Centre Private Limited | ₹104.28 Cr (FY 2024) | -13.0% | Chennai, Tamil Nadu, India | |||
| Cryoviva Biotech Private Limitedthis company | ₹95.95 Cr (FY 2025) | ₹13.74 Cr | 14.3% | -4.0% | 182 | New Delhi, Delhi, India |
| Apollo Fertility Centre Private Limited | ₹94.02 Cr (FY 2025) | 15.0% | Hyderabad, Telangana, India | |||
| Neelam Healthcare Private Limited | ₹86.5 Cr (FY 2025) | 484.0% | Rajpura, Punjab, India | |||
| Lilac Insights Private Limited | ₹77.23 Cr (FY 2025) | 1.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Cryoviva Biotech Private Limited, buy the company report.
Auditor
Cryoviva Biotech Private Limited is audited by O P Bagla & Co LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| O P Bagla & Co LLP | FY 2023 | 000018N/N500091 |
Shareholding
The shareholding of Cryoviva Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cryoviva Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Mar 2017 | 100094304 | Yes Bank Limited | ₹15 Cr | Satisfied | |
| 25 Mar 2014 | 10489903 | Yes Bank Limited | ₹30 Cr | Satisfied | |
| 25 Mar 2014 | 10489902 | Yes Bank Limited | ₹10 Cr | Satisfied | |
| 23 Mar 2011 | 10274447 | Axis Bank Limited | ₹10 Cr | Satisfied | |
| 09 Nov 2006 | 10024446 | Kotak Mahindra Bank Ltd | ₹4 Cr | Satisfied |
To see the full charge records of Cryoviva Biotech Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Cryoviva Biotech Private Limited has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹19.99 Cr; the latest was in February 2021.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2017 | Secondary share transfer | Undisclosed | Buyer: RJ Corp Limited Seller: Devyavni Overseas Private Limited, Devyani Enterprises Private Limited |
| Nov 2011 | Secondary share transfer | Undisclosed | Buyer: Cryobanks International Inc. USA Seller: RJ Corp Limited , Devyavni Overseas Private Limited, R.K Jaipuria & Sons HUF, an individual |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: Devyani Enterprises Private Limited, Devyavni Overseas Private Limited Seller: RJ Corp Limited |
| Sep 2008 | Funding round | ₹9 Cr | Investors: RJ Corp Limited |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: RJ Corp Limited Seller: Artic Drinks Limited |
To see the full deal history of Cryoviva Biotech Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Cryoviva Biotech Private Limited has 83 court cases on record: 78 filed by Cryoviva Biotech, 5 filed against it. 56 cases are pending and 27 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 79 | 2 | 56 |
| High courts | 3 | 2 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 83)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Commercial suit | Filed against the company by Tangence Solutions India Pvt Ltd | Disposed |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Cryoviva Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cryoviva Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cryoviva Biotech Private Limited has a workforce of 182 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Cryoviva Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCC6069Q1Z4 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cryoviva Biotech Private Limited, buy the company report.
Recent activity
Cryoviva Biotech Private Limited has 24 board changes on record since 2005: 15 appointments and 9 cessations. The latest: Upamannyue Roychoudhury ceased to be Whole-Time Director on 15 Dec 2025.
29 earlier events are in the company report.
Frequently asked questions
Cryoviva Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in ivf and maternity care centers, within the healthcare industry. It was incorporated on 20 June 2005 (21+ years old) and is registered under CIN U85195DL2005PTC137768.
Cryoviva Biotech has 6 current directors and KMP:
- Satya Vir Singh - Director
- Satyanarayan Sharma - Director
- Rajesh Chopra - Director
- Raj Pal Gandhi - Director
- Vivek Kumar Singh - Company Secretary
- Ashish Arora - Cfo
The latest financial statements of Cryoviva Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cryoviva Biotech is 06AACCC6069Q1Z4, registered in Haryana.
The CIN (Corporate Identification Number) of Cryoviva Biotech is U85195DL2005PTC137768. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cryoviva Biotech has 83 court cases on record: 78 filed by the company and 5 filed against it. 56 are pending. Most are in the district courts.
Cryoviva Biotech was incorporated on 20 June 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
Cryoviva Biotech has 10 deals on record (7 secondary share transfers, 3 funding rounds), with disclosed funding of ₹19.99 Cr; the latest was in February 2021.
The peers of Cryoviva Biotech by revenue are Star Fertility Private Limited, Arc International Fertility and Research Centre Private Limited, Apollo Fertility Centre Private Limited, Neelam Healthcare Private Limited, Lilac Insights Private Limited, all in the Healthcare industry (IVF and Maternity), with the same principal business activity (other hospital and medical care activities).
Upamannyue Roychoudhury ceased to be Whole-Time Director on 15 Dec 2025. Ashish Arora was appointed as CFO on 28 Nov 2024. Manish Agarwal ceased to be CFO on 22 Nov 2024. Cryoviva Biotech has 24 board changes on record in total.
Cryoviva Biotech can be reached through the website cryoviva.in. Its registered office is in New Delhi, Delhi, India.

